ISPH · Ibnsina Pharma
11.70
EGPUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
EGP13.10B
PE
15.30
EV/EBITDA
9.5
DIV Yield
2.2%
Payout Ratio
34%
MQV Rating
3Neutral
As at 07/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- HALO 100
- HALO 200
- HALO 50
- HALO All
Key Fundamentals
EPS 3 yr Growth
483.10%
EBITDA Margin
5.20%
Operating Cashflow
-£71m
Free Cash Flow Return
-1.80%
ROIC
20.00%
Interest Coverage
1.50
Quick Ratio
0.00
Performance
52 weeks range
Low 9.63 - 16.93
Trade Value (12mth)
US$334,122.00
1 week
-2.66%
1 month
-9.44%
YTD
7.04%
1 year
37.32%
All time high
16.93
Additional Data
Shares Outstanding (Fully Diluted)
0m
HALO Sector
Healthcare
Next Company Report Date
03-Mar-27
Next Ex Dividend Date
12-Oct-26
Next Dividend Pay Date
14-Oct-26
Reporting Currency
EGP
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Neutral
Garp
Strong
Mqv Small
Neutral
Momentum
Price
Neutral
Earnings
Strong
Growth
Earnings
Strong
Dividends
Strong
Quality
Capital Efficiency
Strong
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Abdel Gawad Family | Individual |
| Faisal Islamic Bank of Egypt | Public Company |
| Mahgoub Family | Individual |
| Mohammad Abbas Mohammad Abbas Zaki | Individual |
